BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37143737)

  • 1. Deep learning radiomics model based on breast ultrasound video to predict HER2 expression status.
    Quan MY; Huang YX; Wang CY; Zhang Q; Chang C; Zhou SC
    Front Endocrinol (Lausanne); 2023; 14():1144812. PubMed ID: 37143737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrasound deep learning radiomics and clinical machine learning models to predict low nuclear grade, ER, PR, and HER2 receptor status in pure ductal carcinoma
    Zhu M; Kuang Y; Jiang Z; Liu J; Zhang H; Zhao H; Luo H; Chen Y; Peng Y
    Gland Surg; 2024 Apr; 13(4):512-527. PubMed ID: 38720675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninvasive identification of HER2-low-positive status by MRI-based deep learning radiomics predicts the disease-free survival of patients with breast cancer.
    Guo Y; Xie X; Tang W; Chen S; Wang M; Fan Y; Lin C; Hu W; Yang J; Xiang J; Jiang K; Wei X; Huang B; Jiang X
    Eur Radiol; 2024 Feb; 34(2):899-913. PubMed ID: 37597033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Machine learning-based model constructed from ultrasound radiomics and clinical features for predicting HER2 status in breast cancer patients with indeterminate (2+) immunohistochemical results.
    Yan M; Yao J; Zhang X; Xu D; Yang C
    Cancer Med; 2024 Feb; 13(3):e6946. PubMed ID: 38234171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretreatment ultrasound-based deep learning radiomics model for the early prediction of pathologic response to neoadjuvant chemotherapy in breast cancer.
    Yu FH; Miao SM; Li CY; Hang J; Deng J; Ye XH; Liu Y
    Eur Radiol; 2023 Aug; 33(8):5634-5644. PubMed ID: 36976336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and Validation of an Ultrasound-Based Radiomics Nomogram for Identifying HER2 Status in Patients with Breast Carcinoma.
    Guo Y; Wu J; Wang Y; Jin Y
    Diagnostics (Basel); 2022 Dec; 12(12):. PubMed ID: 36553137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MRI-based machine learning radiomics can predict HER2 expression level and pathologic response after neoadjuvant therapy in HER2 overexpressing breast cancer.
    Bitencourt AGV; Gibbs P; Rossi Saccarelli C; Daimiel I; Lo Gullo R; Fox MJ; Thakur S; Pinker K; Morris EA; Morrow M; Jochelson MS
    EBioMedicine; 2020 Nov; 61():103042. PubMed ID: 33039708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting HER2 Status in Breast Cancer on Ultrasound Images Using Deep Learning Method.
    Xu Z; Yang Q; Li M; Gu J; Du C; Chen Y; Li B
    Front Oncol; 2022; 12():829041. PubMed ID: 35251999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of a clinicoradiomic nomogram to assess the HER2 status of patients with invasive ductal carcinoma.
    Xu A; Chu X; Zhang S; Zheng J; Shi D; Lv S; Li F; Weng X
    BMC Cancer; 2022 Aug; 22(1):872. PubMed ID: 35945526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of HER2 expression in breast cancer by combining PET/CT radiomic analysis and machine learning.
    Chen Y; Wang Z; Yin G; Sui C; Liu Z; Li X; Chen W
    Ann Nucl Med; 2022 Feb; 36(2):172-182. PubMed ID: 34716873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deep learning radiomics of ultrasonography for comprehensively predicting tumor and axillary lymph node status after neoadjuvant chemotherapy in breast cancer patients: A multicenter study.
    Gu J; Tong T; Xu D; Cheng F; Fang C; He C; Wang J; Wang B; Yang X; Wang K; Tian J; Jiang T
    Cancer; 2023 Feb; 129(3):356-366. PubMed ID: 36401611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deep learning radiomics can predict axillary lymph node status in early-stage breast cancer.
    Zheng X; Yao Z; Huang Y; Yu Y; Wang Y; Liu Y; Mao R; Li F; Xiao Y; Wang Y; Hu Y; Yu J; Zhou J
    Nat Commun; 2020 Mar; 11(1):1236. PubMed ID: 32144248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of human epidermal growth factor receptor 2 (HER2) status in breast cancer by mammographic radiomics features and clinical characteristics: a multicenter study.
    Deng Y; Lu Y; Li X; Zhu Y; Zhao Y; Ruan Z; Mei N; Yin B; Liu L
    Eur Radiol; 2024 Jan; ():. PubMed ID: 38276982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integration of ultrasound radiomics features and clinical factors: A nomogram model for identifying the Ki-67 status in patients with breast carcinoma.
    Wu J; Fang Q; Yao J; Ge L; Hu L; Wang Z; Jin G
    Front Oncol; 2022; 12():979358. PubMed ID: 36276108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deep learning radiomics of ultrasonography can predict response to neoadjuvant chemotherapy in breast cancer at an early stage of treatment: a prospective study.
    Gu J; Tong T; He C; Xu M; Yang X; Tian J; Jiang T; Wang K
    Eur Radiol; 2022 Mar; 32(3):2099-2109. PubMed ID: 34654965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One 3D VOI-based deep learning radiomics strategy, clinical model and radiologists for predicting lymph node metastases in pancreatic ductal adenocarcinoma based on multiphasic contrast-enhanced computer tomography.
    Liao H; Yang J; Li Y; Liang H; Ye J; Liu Y
    Front Oncol; 2022; 12():990156. PubMed ID: 36158647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting N2 lymph node metastasis in presurgical stage I-II non-small cell lung cancer using multiview radiomics and deep learning method.
    Zhang H; Liao M; Guo Q; Chen J; Wang S; Liu S; Xiao F
    Med Phys; 2023 Apr; 50(4):2049-2060. PubMed ID: 36563341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasound-based radiomics model for predicting molecular biomarkers in breast cancer.
    Xu R; You T; Liu C; Lin Q; Guo Q; Zhong G; Liu L; Ouyang Q
    Front Oncol; 2023; 13():1216446. PubMed ID: 37583930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of preoperative ultrasound features combined with clinical factors in predicting HER2-positive subtype (non-luminal) breast cancer.
    Zhou J; Jin AQ; Zhou SC; Li JW; Zhi WX; Huang YX; Zhu Q; Qian L; Wu J; Chang C
    BMC Med Imaging; 2021 Dec; 21(1):184. PubMed ID: 34856951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Machine learning analysis of breast ultrasound to classify triple negative and HER2+ breast cancer subtypes.
    Ferre R; Elst J; Senthilnathan S; Lagree A; Tabbarah S; Lu FI; Sadeghi-Naini A; Tran WT; Curpen B
    Breast Dis; 2023; 42(1):59-66. PubMed ID: 36911927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.